Learn More
Apexbio Technology LLC DiscoveryProbe™ Anti-diabetic Compound Library 100uL/well(10 mM solution),96 Well Deep Well Plate

Supplier: Apexbio Technology LLC L10460.096
The DiscoveryProbe Anti-diabetic Compound Library comprises 110 small-molecule compounds including FDA-approved agents designed for diabetes-related biomedical research This collection targets metabolic regulatory pathways involved in diabetes such as dipeptidyl peptidase-4 (DPP-4) sodium-glucose co-transporter (SGLT) poly (ADP-ribose) polymerase (PARP) and ATP-sensitive potassium channels Representative compounds include metformin glibenclamide empagliflozin rosiglitazone and sitagliptin This library serves as a resource for investigating the molecular mechanisms of diabetes conducting potential therapeutic screening studies and developing novel diabetes-relevant research models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.